Li, Dan
He, Wu
Yu, Bo
Wang, Dao Wen
Ni, Li
Clinical trials referenced in this document:
Documents that mention this clinical trial
NT-proBNP ratio is a potential predictor for COVID-19 outcomes in adult Chinese patients: a retrospective study
https://doi.org/10.1038/s41598-024-56329-2
Documents that mention this clinical trial
NT-proBNP ratio is a potential predictor for COVID-19 outcomes in adult Chinese patients: a retrospective study
https://doi.org/10.1038/s41598-024-56329-2
Funding for this research was provided by:
National Natural Science Foundation of China (82100526, No. 82330010, No. 82241034, 82070354, 81470519)
Article History
Received: 26 October 2023
Accepted: 5 March 2024
First Online: 11 March 2024
Competing interests
: The authors declare no competing interests.